Connection
Philip Zeitler to Imatinib Mesylate
This is a "connection" page, showing publications Philip Zeitler has written about Imatinib Mesylate.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.022 |
|
|
|
-
Hobernicht SL, Schweiger B, Zeitler P, Wang M, Hunger SP. Acquired growth hormone deficiency in a girl with chronic myelogenous leukemia treated with tyrosine kinase inhibitor therapy. Pediatr Blood Cancer. 2011 Apr; 56(4):671-3.
Score: 0.022